Purchases and Sales Made in Q1 2025 in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN) during Q1 2025. The information is specifically focused on institutions that hold shares of Terns Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-493K- 30.6% |
$1.36M - $2.85M
|
1.12M
$6.4M
|
|
|
May 13, 2025
Q1 2025
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-600K- 95.51% |
$1.66M - $3.48M
|
28.2K
$162K
|
|
|
May 15, 2025
Q1 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-659K- 81.99% |
$1.82M - $3.81M
|
145K
$829K
|
|
|
May 15, 2025
Q1 2025
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-663K- 32.83% |
$1.83M - $3.84M
|
1.36M
$7.78M
|
|
|
May 15, 2025
Q1 2025
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-898K- 54.06% |
$2.48M - $5.2M
|
763K
$4.37M
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-907K- 19.08% |
$2.5M - $5.25M
|
3.84M
$22M
|
|
|
May 15, 2025
Q1 2025
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.09M- 87.16% |
$3.01M - $6.32M
|
161K
$921K
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.43M- 94.94% |
$3.94M - $8.27M
|
76.1K
$436K
|